Scientific Methodology & Mathematical Logic
LongevityReviews.org operates as an open, evidence-anchored consensus platform for human longevity science. Rather than relying on editorial opinions or influencer anecdotes, every score across our platform is computed using peer-reviewed clinical research, established epidemiological frameworks, and reproducible mathematical algorithms.
Adherence to Global Clinical Standards
Wherever accepted international methodologies exist for rating clinical evidence, we adhere to them strictly rather than inventing proprietary black boxes.
Hierarchical study design weighting: Systematic Reviews & Meta-Analyses (Level 1) down to In Vitro assays (Level 5).
International consensus standard for evidence certainty: High (A), Moderate (B), Low (C), and Very Low (D).
Systematic auditing of randomization, blinding, selective reporting, and commercial conflict-of-interest penalties.
Cellular damage mapping across Primary, Antagonistic, and Integrative hallmarks with exponential saturation modeling.
Actionable physiological mapping anchored to hard clinical endpoints (ApoB, VO2 Max, HOMA-IR, hs-CRP, DEXA BMD).
Multi-parametric 4-factor deterministic scoring model: evidence grade, effect magnitude, specificity, and reproducibility.
The Deterministic 0–99 Clinical Efficacy Index (CEI)
All functional outcomes and longevity metrics are calibrated on a continuous 0–99 integer scale. We deliberately avoid a 100-point ceiling because in biological sciences, declaring 100% certainty is scientifically invalid. Furthermore, a 0–99 scale provides the necessary statistical resolution to separate high-performing protocols from elite physiological anchors without compression.
Where each dimension is evaluated against a verified empirical ledger of published clinical trials.
Anchored to the Oxford CEBM study hierarchy:
- • Cochrane Review / Meta-Analysis:34–35 pts
- • Double-Blind Placebo RCT:30–33 pts
- • Prospective Human Cohort (N > 500):25–29 pts
- • ITP Lifespan / Animal Biomarker:20–24 pts
- • Observational / In Vitro:12–19 pts
Derived directly from quantitative biomarker deltas or Cohen's d:
- • Very High (d ≥ 0.80 or ≥ 25% delta):32–35 pts
- • High (d = 0.50–0.79 or 12–24% delta):27–31 pts
- • Moderate (d = 0.30–0.49 or 5–11% delta):20–26 pts
- • Mild / Secondary Cross-Talk (< 5%):12–19 pts
Assesses whether the intervention acts directly on the target tissue or through indirect downstream cascades:
- • Direct Primary Tissue Target:19–20 pts
- • Secondary Downstream Signaling:14–18 pts
- • Correlative / Tertiary Cross-Talk:8–13 pts
Reflects latency to clinical manifestation and human responder consistency:
- • Acute / Deterministic (< 60 min, 100%):9–10 pts
- • Sub-acute (1–4 weeks, high responder):7–8 pts
- • Chronic (8–24 weeks, variable response):4–6 pts
Multi-Study Epistemic Weighting & Bias Auditing
When multiple published trials exist for an intervention, we do not simply take the best result or an unweighted average. Instead, each trial is weighted according to sample size log-scaling, trial design hierarchy, and Cochrane Risk of Bias scores.
Sample Size Log-Scaling
Sample power is scaled logarithmically:f(N) = min(1.4, max(0.5, log₁₀(N + 10) / 3.0))This ensures an N=1,500 multi-center trial properly anchors the score over an N=14 pilot study without skewing calculations to infinity.
Cochrane Risk of Bias 2
Trials receive a risk-of-bias score from 1.0 (minimal risk) to 5.0 (high risk):Penalty = 1.0 - ((RoB - 1.0) / 4.0) × 0.22Trials with unblinded participants, missing attrition logs, or heavy industry funding are penalized up to 22%.
Dynamic Confidence Intervals
Every score presents an explicit error boundary based on literature depth:CI = ± max(1.6, min(6.5, 14.0 / √(k × log₁₀(N+10))))Well-researched anchors (Creatine, Zone 2) narrow to ±1.8%, while emerging molecules widen to ±4.2%.
Dual-Radar Mapping: 12 Hallmarks & 8 Canonical Vectors
To bridge microscopic cellular mechanisms with macro physiological health, every modality in LongevityReviews is evaluated across two distinct clinical coordinate systems:
The 12 Hallmarks of Aging
Derived from López-Otín et al. (Cell 2013, 2023), categorized into three evolutionary tiers:
The 8 Canonical Longevity Vectors
Actionable organ and system domains anchored directly to measurable laboratory biomarkers:
Differentiated Physiological Potential Mathematics
In human biology, achieving 90% of your physiological potential for Muscular Strength is fundamentally different than achieving 90% for Sleep Onset Latency. A universal flat formula distorts reality. Our epistemic framework introduces a crucial two-tier distinction:
Measures the isolated, peer-reviewed human RCT evidence of a single intervention. On modality pages, Resistance Training is rated 98/100 for Muscular Strength because it is the undisputed gold-standard mechanical stimulus in clinical literature.
Measures what percentage of total human potential is fulfilled by a complete protocol. Doing only heavy lifting without protein substrate, cellular creatine, and deep sleep leaves ~33% of strength potential on the table, fulfilling only 67% of total potential.
The Four Mechanistic Physiological Complexity Classes
Signal-gated biophysical switches (Sleep Latency, Alertness, Satiety, Calmness). A single landmark modality unlocks ~80% of human potential.
Homeostatic balancing (Soreness/DOMS, Stress, Mood, Digestive Comfort). Requires co-equal thermal/vagal flush combined with cellular hydration.
Central vs. peripheral limits (Endurance, Energy, Focus, Sleep Architecture). Requires pairing central cardiac/PFC limits with peripheral cellular engines.
Tissue synthesis (Strength, Joint Comfort, Skin, Immune, Bone). Strictly requires Stimulus + Substrate + Cellular Bioenergetics + Slow-Wave Rest.
Where $E_1 \ge E_2 \ge \dots$ are constituent modality clinical ratings, $\alpha_o$ is the outcome-specific biological ceiling factor, and $w_o$ is the orthogonal expansion vector. 100/100 is eliminated as a biologically unattainable asymptote.
- • Lifting Alone (98) → 67/100 (Leaves 33% unfulfilled)
- • + Protein Distribution (94) → 80/100 (Unlocks amino substrate)
- • + Creatine Monohydrate (91) → 86/100 (Intramuscular phosphocreatine)
- • + Deep Sleep Recovery (85) → 88/100 (Anabolic GH pulse)
- • 65°F Cool Dark Room (95) → 76/100 (Core temperature dump)
- • + Glycine / Apigenin (90) → 86/100 (Central GABAergic disinhibition)
- • + Morning Sunlight (88) → 89/100 (SCN circadian phase-advance)
- • Elite Multi-System Sleep Blueprint → 91/100
The 8 Systemic Longevity Vectors: Organ-System Potential Fulfillment
Single-Modality Ceiling: ~65–68%While daily wellbeing outcomes track immediate functional performance, the 8 Systemic Longevity Vectors represent the chronic structural resilience of major organ systems. Because organ failure or degenerative decline emerges through multiple orthogonal pathways, no single intervention can ever provide complete protection. For example, practicing Zone 2 Cardio with elite consistency produces a pristine clinical trial efficacy rating (98/100), yet fulfills only 66% of total cardiovascular longevity potential if circulating ApoB particles, left ventricular stroke volume (Zone 5 / VO2 Max), and arterial calcification remain unaddressed.
- • Pillar 1: Endothelial Protection & Nitric Oxide (Zone 2)
- • Pillar 2: ApoB Clearance & Plaque Stasis (Lipid control)
- • Pillar 3: Peak VO2 Max Stroke Volume (Zone 5 HIIT)
- • Pillar 4: Arterial Decalcification & Elasticity (K2/MK-7, BP)
- • Pillar 1: Glymphatic Clearance (Slow-wave deep sleep)
- • Pillar 2: Hippocampal Neuroplasticity & BDNF (Cardio / Sauna)
- • Pillar 3: Cerebral Perfusion & Nitric Oxide (Vascular flow)
- • Pillar 4: Neuroinflammation Dampening (Omega-3 DHA/EPA)
- • Pillar 1: GLUT4 Translocation & Muscle Glucose Sink (Resistance)
- • Pillar 2: Hepatic Fatty Acid Oxidation & Ketogenesis (Fasting)
- • Pillar 3: Mitochondrial Substrate Switching (Zone 2)
- • Pillar 4: Postprandial Glycemic Attenuation (Fiber, Berberine)
- • Pillar 1: Natural Killer (NK) Cell Immunosurveillance (Exercise)
- • Pillar 2: Mutagenic Stress Reduction & DNA Repair (Sulforaphane)
- • Pillar 3: Growth Factor Normalization (IGF-1 / mTOR cycling)
- • Pillar 4: Multi-Cancer Early Detection (Liquid Biopsy / MRI)
The 12 Hallmarks of Aging (López-Otín et al., 2023): Cellular Damage Saturation Engine
Single-Modality Ceiling: ~64–68%The 12 Hallmarks of Aging represent the root molecular and cellular drivers of organismal decline. The engine classifies hallmarks into their canonical three-tier hierarchy: Primary (initiating molecular damage), Antagonistic (adaptive responses that turn deleterious at chronicity), and Integrative (macroscopic tissue failure).
Cellular senescence involves irreversible cell cycle arrest coupled with a hyper-inflammatory Senescence-Associated Secretory Phenotype (SASP). A pure senolytic modality (e.g., high-dose Fisetin) achieves an exceptional clinical trial efficacy score (93/100), but only fulfills 65% of the potential on this hallmark because killing senescent cells without suppressing the SASP in surviving cells, stimulating autophagic clearance, or supporting NK-cell mediated elimination leaves underlying paracrine toxicity unaddressed.
The Tripartite Taxonomy & 2-Tier Data Architecture
LongevityReviews.org acts as the public consensus intelligence layer, while the LEVL Protocols App acts as the personal adherence, daily routine tracking, and wearable verification layer. Both applications query and update the same unified Supabase schema.
The 25 Practical Daily Wellbeing Outcomes
These 25 canonical tracking slugs represent the exact daily wellness objectives users select and monitor in the LEVL app:
Where We Draw the Separation Line: Comparability vs. Distinctiveness
A fundamental dilemma in health platform design is balancing cross-modality comparability (e.g. sorting and filtering protocols) with scientific distinctiveness (capturing the precise biological mechanism of a specific compound). We solve this using a strict 2-Tier Architecture:
The Grouping & Query Key
The database key (in functional_outcomes_to_track and functional_impacts) MUST always be one of the standardized canonical slugs. This guarantees:
- Instant filtering and cross-modality leaderboard sorting
- Reliable multi-protocol radar chart stacking
- 100% interoperability with user goal pickers in the LEVL mobile app
The Granular Scientific Proof
Inside each canonical bucket, the modality attaches its specific clinical findings, keeping scientific nuances fully preserved without polluting the grouping keys:
- Specific biomarker measured (e.g. ³¹P-MRS prefrontal phosphocreatine)
- Quantitative delta and p-value (+9.2% ATP resynthesis, p=0.003)
- Exact peer-reviewed PubMed citations (PMID 33578876)
| Database Field | Data Type | Description & Operational Role | Example Value |
|---|---|---|---|
| primary_outcome | text | Headline clinical objective of the intervention | "Muscular Strength & Cognitive Bioenergetics" |
| secondary_outcomes | text[] | Array of 3–5 secondary clinical endpoints | ["Working Memory", "Bone Mineral Density"] |
| functional_outcomes_to_track | text[] | Standardized LEVL snake_case tracking slugs (from the 25 canonical options) | ["strength", "focus", "energy", "recovery"] |
| functional_impacts | jsonb | Title Case mapping of 0–99 score, magnitude & distinctive studies | {"Strength": {"score": 96, "effect_magnitude": "very_high"}} |
| modality_studies | relational table | Granular trial ledger with PMIDs, sample size & delta % | PMID 14636102 (N=500+, 1RM strength +14%) |